vTv Therapeutics, Inc. (VTVT)
30.58
+0.12
(+0.38%)
USD |
NASDAQ |
Sep 16, 16:00
30.58
0.00 (0.00%)
After-Hours: 20:00
vTv Therapeutics Price to Book Value : 1.532 for Sept. 16, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 1.526 |
| September 14, 2026 | 1.575 |
| September 11, 2026 | 1.601 |
| September 10, 2026 | 1.596 |
| September 09, 2026 | 1.668 |
| September 08, 2026 | 1.642 |
| September 04, 2026 | 1.671 |
| September 03, 2026 | 1.677 |
| September 02, 2026 | 1.673 |
| September 01, 2026 | 1.600 |
| August 31, 2026 | 1.603 |
| August 28, 2026 | 1.621 |
| August 27, 2026 | 1.643 |
| August 26, 2026 | 1.682 |
| August 25, 2026 | 1.699 |
| August 24, 2026 | 1.698 |
| August 21, 2026 | 1.666 |
| August 20, 2026 | 1.657 |
| August 19, 2026 | 1.648 |
| August 18, 2026 | 1.577 |
| August 17, 2026 | 1.568 |
| August 14, 2026 | 1.509 |
| August 13, 2026 | 1.545 |
| August 12, 2026 | 1.592 |
| August 11, 2026 | 1.655 |
| Date | Value |
|---|---|
| August 10, 2026 | 1.718 |
| August 07, 2026 | 1.772 |
| August 06, 2026 | 1.734 |
| August 05, 2026 | 1.723 |
| August 04, 2026 | 1.606 |
| August 03, 2026 | 1.622 |
| July 31, 2026 | 1.620 |
| July 30, 2026 | 1.637 |
| July 29, 2026 | 1.577 |
| July 28, 2026 | 1.557 |
| July 27, 2026 | 1.554 |
| July 24, 2026 | 1.539 |
| July 23, 2026 | 1.586 |
| July 22, 2026 | 1.586 |
| July 21, 2026 | 1.648 |
| July 20, 2026 | 1.622 |
| July 17, 2026 | 1.647 |
| July 16, 2026 | 1.618 |
| July 15, 2026 | 1.638 |
| July 14, 2026 | 1.597 |
| July 13, 2026 | 1.582 |
| July 10, 2026 | 1.678 |
| July 09, 2026 | 1.675 |
| July 08, 2026 | 1.735 |
| July 07, 2026 | 1.709 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Spyre Therapeutics, Inc. | 8.414 |
| ACADIA Pharmaceuticals, Inc. | 3.626 |
| Alnylam Pharmaceuticals, Inc. | 23.65 |
| Anika Therapeutics, Inc. | 2.034 |
| Savara, Inc. | 7.349 |
Price to Book Value Related Metrics
| PS Ratio | 9.858 |
| Price | 30.58 |
| Earnings Yield | -3.46% |
| Market Cap | 120.43M |